Compulsory licensing issues and trends in Asia

ISSN： 2046-8954

Source： Pharmaceutical Patent Analyst, Vol.2, Iss.6, 2013-11, pp. : 681-683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Compulsory licensing of pharmaceuticals justified?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 389, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Learning from practice: compulsory licensing cases and access to medicines

By Stirner Beatrice Thangaraj Harry

Pharmaceutical Patent Analyst, Vol. 2, Iss. 2, 2013-03 ,pp. : 195-213

Future Science

Access to resources Recommend Favorite

Compulsory pharmaceutical patent licensing in Brazil: the controversy of public interest

By Rodrigues da Silva Caio Galvão de Botton Leonor

Pharmaceutical Patent Analyst, Vol. 2, Iss. 6, 2013-11 ,pp. : 685-687

Future Science

Access to resources Recommend Favorite

Herbal Remedies: Issues in Licensing and Economic Evaluation

By Ashcroft D.M. Li Wan Po A.

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 321-328

Adis International

Access to resources Recommend Favorite

Developing Health-Related Quality-of-Life Instruments for Use in Asia: The Issues

By Yin Bun Cheung Thumboo Julian

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 643-650

Adis International

Access to resources Recommend Favorite